Leveraging Real World Evidence to Differentiate Your In-Vitro Diagnostics

9 Pages

This brief examines how real-world evidence (RWE) can support regulatory, clinical, and market access strategies for in-vitro diagnostics (IVDs). It explains how RWE complements traditional performance studies across the product lifecycle, from pre-market evidence generation to post-market validation. The brief discusses study design considerations, patient-centric methodologies, and novel data sources. IQVIA positions RWE as a key differentiator for accelerating adoption, reimbursement, and competitive positioning.

Join for free to read

Case Study The in-vitro diagnostics regulation (IVDR): From oversight to…

White Paper Generating evidence for digital health solutions

White Paper THE HEALTHCARE & LIFE SCIENCES DATA CLOUD FOR REAL-WORLD EVIDENCE

White Paper Making Real-World Evidence Meaningful and Actionable

More from IQVIA

White Paper Making Real-World Evidence Meaningful and Actionable

Ebook Advancing Digital Health Innovation Using Real World Evidence

Case Study Closing Data Gaps: Real World Evidence Generation Enhanced by…

White Paper Efficient Real World Evidence Generation with Enriched Methods

Ebook

Leveraging Real World Evidence to Differentiate Your In-Vitro Diagnostics

Leveraging Real World Evidence to Differentiate Your In-Vitro Diagnostics

You Might Also Like

More from IQVIA